JANET HEMINGWAY CBE

Director of iiCON: Infection Innovation Consortium.

Janet Hemingway is founding Director of the Infection Innovation Consortium (iiCON) and Professor of Tropical Medicine at the Liverpool School of Tropical Medicine (LSTM). Responding to the growing challenge of infectious diseases, antimicrobial resistance, and emerging pandemics, iiCON brings together academic, industry, and clinical partners in a £170 million programme to transform the discovery and supply of much-needed anti-infectives and accelerate their journey to market.

She is a senior technical advisor on Neglected Tropical Diseases for the Bill and Melinda Gates Foundation and has been PI on projects in excess of £370 million including the BMGF funded Innovative Vector Control Consortium, the ERDF funded Formulations programme and the BMGF funded Visceral Leishmaniasis Elimination programme.

Professor Hemingway was appointed the Director of LSTM in 2001 and stepped down on 1st January 2019.

She was awarded a CBE for services to the Control of Tropical Disease Vectors in 2012.